BlackRock Health Sciences Term Trust $BMEZ Shares Acquired by Penserra Capital Management LLC

Penserra Capital Management LLC lifted its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 15.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,332,633 shares of the company’s stock after buying an additional 175,629 shares during the period. Penserra Capital Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $19,216,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in BMEZ. Chapin Davis Inc. boosted its stake in shares of BlackRock Health Sciences Term Trust by 3.2% in the third quarter. Chapin Davis Inc. now owns 27,605 shares of the company’s stock valued at $398,000 after buying an additional 849 shares in the last quarter. Truist Financial Corp lifted its stake in shares of BlackRock Health Sciences Term Trust by 5.9% in the second quarter. Truist Financial Corp now owns 19,645 shares of the company’s stock valued at $280,000 after purchasing an additional 1,093 shares during the period. Brown Lisle Cummings Inc. boosted its holdings in BlackRock Health Sciences Term Trust by 3.4% during the third quarter. Brown Lisle Cummings Inc. now owns 46,666 shares of the company’s stock worth $673,000 after buying an additional 1,554 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in shares of BlackRock Health Sciences Term Trust by 14.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 14,521 shares of the company’s stock worth $212,000 after acquiring an additional 1,787 shares during the period. Finally, Geneos Wealth Management Inc. acquired a new position in BlackRock Health Sciences Term Trust during the first quarter worth $40,000.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In other news, Director Robert W. Fairbairn sold 10,294 shares of the company’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $14.98, for a total value of $154,204.12. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock opened at $15.13 on Thursday. The stock has a fifty day moving average of $15.29 and a two-hundred day moving average of $14.78. BlackRock Health Sciences Term Trust has a fifty-two week low of $12.58 and a fifty-two week high of $16.61.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 13th will be issued a $0.11 dividend. The ex-dividend date is Friday, March 13th. This represents a c) annualized dividend and a yield of 8.7%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.